Given that PPARγ plays a significant role in anti-inflammatory response [34, 35], we wanted to test if PPARγ activation inhibits the pro-inflammatory COX2 expression in the lung cancer pathogenesis model. This evidence concerns the gene PPARG and lung carcinoma.